10.89 +0.03 (0.27%)
After hours: 4:11PM EDT
|Bid||9.65 x 2200|
|Ask||11.88 x 2900|
|Day's Range||10.73 - 11.04|
|52 Week Range||8.54 - 13.88|
|Beta (3Y Monthly)||1.47|
|PE Ratio (TTM)||10.25|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...
In 2012 Paul Black was appointed CEO of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX). This analysis aims first...
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
AllScripts (MDRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Cooper Companies (COO) is gaining traction from expansion in international markets, robust product portfolio across segments and prudent acquisitions.
Allscripts (MDRX) second-quarter results gain from growth in bookings and solid show by client services segment. Contraction in operating margin remains a woe.
AllScripts (MDRX) delivered earnings and revenue surprises of 6.25% and -0.72%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
AllScripts (MDRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Allscripts Healthcare...